Chugai Pharmaceutical receives Porter Prize as Chugai Pharmaceutical stock trades at EUR 35.38
Published on 10/18/2026 at 17:13 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSWeekend trading and company news
- Chugai Pharmaceutical announced its Porter Prize 2026 recognition on October 16, 2026.
- Chugai Pharmaceutical stock trades in weekend trading at Lang & Schwarz at EUR 35.38 at 5:10 p.m. CEST on October 18, 2026.
- The next Xetra session is scheduled for October 19, 2026.
Chugai Pharmaceutical announced on October 16, 2026, that it had received Porter Prize 2026, organized by the Graduate School of International Corporate Strategy at Hitotsubashi University. The award recognized Chugai's technology-driven drug discovery approach and business model, according to the company's release.
Market context: Market report Nikkei 225.
Weekend trading
Chugai Pharmaceutical stock trades in weekend trading at Lang & Schwarz at EUR 35.38 at 5:10 p.m. CEST on October 18, 2026. The bid was EUR 35.10 and the ask was EUR 35.66. The further course of weekend trading at Lang & Schwarz until 7:00 p.m. CET/CEST is shown by the continuously updated real-time quote of Chugai Pharmaceutical stock.
The week in figures
The Lang & Schwarz price was EUR 35.38 at 5:10 p.m. CEST on October 18, 2026. The quote was recorded during weekend trading, while Xetra and the primary exchanges were closed.
Chronology of the week
On October 16, 2026, Chugai announced its receipt of Porter Prize 2026. The award was the first Porter Prize received by Chugai and the first awarded to a pharmaceutical company in 19 years, according to the company's announcement.
Also on October 16, 2026, Chugai reported that the U.S. Food and Drug Administration had approved Roche's Enspryng for the treatment of thyroid eye disease. Chugai's announcement identified Roche as the issuer of the related media release.
Dates of the coming week
The next Xetra session is scheduled for October 19, 2026.
